Ophthalmic Drugs Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	171 Pages	Coherent Market Insights	May, 2023	CMI18001207

Best Price Guarantee
Price	from $4,500
Length	171 Pages
Publisher	Coherent Market Insights
Published Date	May, 2023
SKU	CMI18001207

Ophthalmic Drugs Market, By Indication ((Dry Eye, Glaucoma, Infection/Inflammation/Allergy, Retinal Disorders (Wet Age-related Macular Degeneration, Dry Age-related Macular Degeneration, Diabetic Retinopathy, and Others), and Others), By Type (Prescription Drugs and Over-the-counter Drugs), By Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, and Other Ophthalmic Drug Forms), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others), By Therapeutic Class (Anti-glaucoma, Anti-infection, Anti-inflammation, Anti-allergy, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Ophthalmology is a specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology, and diseases that may affect the eye. Whereas, ophthalmic drugs are used to treat various disorders associated with the eyes, such as cataracts, glaucoma, infection, allergy, and inflammation, retinal disorders (such as wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others), and other ophthalmic disorders.

Market Dynamics:

Rise in prevalence of ophthalmic disorders, growing geriatric population, rise in demand for safe and effective ophthalmic drugs, rise in focus on the development of ophthalmic drugs, and increase in research and development are major factors expected to propel growth of the global ophthalmic drugs market during the forecast period.

For instance, in April 2022, Sandoz announced the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, AB-rated generic equivalent to AbbVie’s COMBIGAN, to lower eye pressure in patients with ocular hypertension. Moreover, in March 2022, Théa Pharma acquired seven branded ophthalmic products from Akorn Operating Company LLC to strengthen its position as a significant provider of products developed to satisfy the demands of eye care specialists across the United States.

Key features of the study:

This report provides in-depth analysis of the global ophthalmic drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global ophthalmic drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbvie Inc. (Allergan Plc), Alcon, Inc., Novartis AG, Pfizer Inc., Bausch & Lomb Incorporated, F. Hoffmann-LA Roche Ltd. (Genentech, Inc.), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global ophthalmic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ophthalmic drugs market.

Detailed Segmentation:

Global Ophthalmic Drugs Market, By Indication:

Dry Eye

Glaucoma

Infection/Inflammation/Allergy

Retinal Disorder
Wet Age-related Macular Degeneration
Dry Age-related Macular Degeneration
Diabetic Retinopathy
Others

Others

Global Ophthalmic Drugs Market, By Type:

Prescription Drugs

Over-the-counter Drugs

Global Ophthalmic Drugs Market, By Dosage Form:

Liquid Ophthalmic Drug Forms

Solid Ophthalmic Drug Forms

Semisolid Ophthalmic Drug Forms

Multicompartment Drug Delivery Systems

Other Ophthalmic Drug Forms

Global Ophthalmic Drugs Market, By Distribution Channel:

Hospital Pharmacies

Drug Stores

Online Pharmacies

Others

Global Ophthalmic Drugs Market, By Therapeutic Class:

Anti-glaucoma

Anti-infection

Anti-inflammation

Anti-allergy

Others

Global Ophthalmic Drugs Market, By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Company Profiles:

Abbvie Inc. (Allergan Plc)

Alcon, Inc.

Novartis AG

Pfizer Inc.

Bausch & Lomb Incorporated

F.Hoffmann-LA Roche Ltd. (Genentech, Inc.)

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Indication; Market Snapshot, By Type; Market Snapshot, By Dosage Form; Market Snapshot, By Distribution Channel; Market Snapshot, By Therapeutic Class; Market Snapshot, By Geography; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing prevalence of ophthalmic disorders; Risks associated with ophthalmic drugs; High demand for safe/effective ophthalmic drugs; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Ophthalmic Drugs Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Ophthalmic Drugs Market, By Indication, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Dry Eye; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Glaucoma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Infection/Inflammation/Allergy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Retinal Disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Wet Age-related Macular Degeneration; Dry Age-related Macular Degeneration; Diabetic Retinopathy; Others; Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
6. Global Ophthalmic Drugs Market, By Type, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Prescription Drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Over-the-counter Drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
7. Global Ophthalmic Drugs Market, By Dosage Form, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Liquid Ophthalmic Drug Forms; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Solid Ophthalmic Drug Forms; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Semisolid Ophthalmic Drug Forms; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Multicompartment Drug Delivery Systems; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Other Ophthalmic Drug Forms; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
8. Global Ophthalmic Drugs Market, By Distribution Channel, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Drug Stores; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
9. Global Ophthalmic Drugs Market, By Therapeutic Class, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Anti-glaucoma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Anti-infection; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Anti-inflammation; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Anti-allergy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); 10. Global Ophthalmic Drugs Market, By Geography, 2017-2030, (US$ Bn); Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2017-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2017-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2017-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2017-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2017-2030,(US$ Bn); 11. Competitive Landscape; Abbvie Inc. (Allergan Plc); Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Alcon, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Novartis AG; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Pfizer Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Bausch & Lomb Incorporated; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; F. Hoffmann-LA Roche Ltd. (Genentech, Inc.); Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views; 12. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Ophthalmic Drugs Market” - forecast to 2030